Demystifying Demyelination - A Multiple Sclerosis Treatment Review



Speaker Information

Cori Shope, PharmD, BCACP, CPP
Clinical Pharmacist Practitioner

Novant Health Neurology, Wilmington, NC


Learning Objectives:

  • Describe the pathophysiology and clinical features of multiple sclerosis
  • Differentiate between classifications of multiple sclerosis
  • Discuss disease-modifying therapies available for the treatment of multiple sclerosis
  • Assess safety considerations and monitoring requirements for disease-modifying therapies

 Description: Multiple sclerosis is a central nervous system demyelinating disease that can cause a range of disability for persons affected. Autoimmune attacks on the brain, spinal cord, or optic nerves may lead to symptoms such as problems with vision, arm or leg movement, spasticity, sensation, and balance. With no cure for multiple sclerosis available, this program will highlight medications used as disease-modifying therapies intended to prevent further clinical flares and slow progression to disability.


Members: FREE
Non-Members: $25.00

Date: Sunday, July 21
Time: 6:00 pm - 7:00 pm

ACPE accredited for 1.0-hour


Upcoming Live Webinar Event